The neuropeptide VIP regulates the expression of osteoclastogenic factors in osteoblasts (Q42611864)

3 November 2017

The neuropeptide VIP regulates the expression of osteoclastogenic factors in osteoblasts (English)

1 reference

3 November 2017

0 references

2

Ulf H Lerner

1 reference

3 November 2017

Emma Persson

1

1 reference

3 November 2017

1 December 2011

1 reference

Journal of Cellular Biochemistry

3 November 2017

1 reference

3 November 2017

112

1 reference

3 November 2017

3732-3741

1 reference

3 November 2017

12

1 reference

Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells

3 November 2017

1 reference

Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues.

21 January 2018

1 reference

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

21 January 2018

1 reference

Chemical sympathectomy impairs bone resorption in rats: a role for the sympathetic system on bone metabolism.

21 January 2018

1 reference

Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects

21 January 2018

1 reference

RANK is essential for osteoclast and lymph node development

21 January 2018

1 reference

The two faces of serotonin in bone biology

21 January 2018

1 reference

Leptin regulation of bone resorption by the sympathetic nervous system and CART

21 January 2018

1 reference

Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein

21 January 2018

1 reference

Rapid neural growth: calcitonin gene-related peptide and substance P-containing nerves attain exceptional growth rates in regenerating deer antler

21 January 2018

1 reference

Intracellular signaling molecules involved in vasoactive intestinal peptide-mediated wound healing in human bronchial epithelial cells.

21 January 2018

1 reference

An improved method for preparing cryostat sections of undecalcified bone for multiple uses

21 January 2018

1 reference

Functional Receptors for Vasoactive Intestinal Peptide on Human Osteosarcoma Cells*

21 January 2018

1 reference

Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers.

21 January 2018

1 reference

Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis

21 January 2018

1 reference

Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis.

21 January 2018

1 reference

Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells

21 January 2018

1 reference

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures

21 January 2018

1 reference

NEW MOLECULES IN THE TUMOR NECROSIS FACTOR LIGAND AND RECEPTOR SUPERFAMILIES WITH IMPORTANCE FOR PHYSIOLOGICAL AND PATHOLOGICAL BONE RESORPTION.

21 January 2018

1 reference

Helodermin, helospectin, and PACAP stimulate cyclic AMP formation in intact bone, isolated osteoblasts, and osteoblastic cell lines

21 January 2018

1 reference

Osteoimmunology: interactions of the bone and immune system

21 January 2018

1 reference

Neuro-hormonal control of bone metabolism: vasoactive intestinal peptide stimulates alkaline phosphatase activity and mRNA expression in mouse calvarial osteoblasts as well as calcium accumulation mineralized bone nodules

21 January 2018

1 reference

Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors

21 January 2018

1 reference

Osteoclasts and the immune system

21 January 2018

1 reference

The neuropeptide VIP potentiates IL-6 production induced by proinflammatory osteotropic cytokines in calvarial osteoblasts and the osteoblastic cell line MC3T3-E1.

21 January 2018

1 reference

Increased expression of interleukin-6 by vasoactive intestinal peptide is associated with regulation of CREB, AP-1 and C/EBP, but not NF-kappaB, in mouse calvarial osteoblasts

21 January 2018

1 reference

Microisolated mouse osteoclasts express VIP-1 and PACAP receptors.

21 January 2018

1 reference

alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology

21 January 2018

1 reference

Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells

21 January 2018

1 reference

Osteoprotegerin deficiency and juvenile Paget's disease.

21 January 2018

1 reference

Central regulation of bone mass

21 January 2018

1 reference

A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure

21 January 2018

1 reference

Vasoactive intestinal peptide induces vascular endothelial growth factor production in human HaCaT keratinocytes via MAPK pathway

21 January 2018

1 reference

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.23304

1 reference

3 November 2017

1 reference

PubMed ID

21815197